Cargando…
Inhibition of G0/G1 Switch 2 Ameliorates Renal Inflammation in Chronic Kidney Disease
Chronic kidney disease (CKD) is a global health problem, and novel therapies to treat CKD are urgently needed. Here, we show that inhibition of G(0)/G(1) switch 2 (G0s2) ameliorates renal inflammation in a mouse model of CKD. Renal expression of chemokine (C-C motif) ligand 2 (Ccl2) was increased in...
Autores principales: | Matsunaga, Naoya, Ikeda, Eriko, Kakimoto, Keisuke, Watanabe, Miyako, Shindo, Naoya, Tsuruta, Akito, Ikeyama, Hisako, Hamamura, Kengo, Higashi, Kazuhiro, Yamashita, Tomohiro, Kondo, Hideaki, Yoshida, Yuya, Matsuda, Masaki, Ogino, Takashi, Tokushige, Kazutaka, Itcho, Kazufumi, Furuichi, Yoko, Nakao, Takaharu, Yasuda, Kaori, Doi, Atsushi, Amamoto, Toshiaki, Aramaki, Hironori, Tsuda, Makoto, Inoue, Kazuhide, Ojida, Akio, Koyanagi, Satoru, Ohdo, Shigehiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264248/ https://www.ncbi.nlm.nih.gov/pubmed/27745900 http://dx.doi.org/10.1016/j.ebiom.2016.10.008 |
Ejemplares similares
-
Molecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic pain
por: Kusunose, Naoki, et al.
Publicado: (2010) -
RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene
por: Omata, Yuji, et al.
Publicado: (2021) -
Alteration of circadian machinery in monocytes underlies chronic kidney disease-associated cardiac inflammation and fibrosis
por: Yoshida, Yuya, et al.
Publicado: (2021) -
RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells
por: Omata, Yuji, et al.
Publicado: (2022) -
Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice
por: Tsuruta, Akito, et al.
Publicado: (2022)